PRF Technologies (PRFX) Interest Expenses (2019 - 2025)
PRF Technologies (PRFX) posted Interest Expenses of $13.2 million for Q4 2025, up 29.07% on a QoQ basis from $10.2 million in Q4 2024, and up 29.07% year-over-year from $10.2 million in Q4 2024.
PRF Technologies (PRFX) Interest Expenses (2019 - 2025) Analysis & Trends
PRF Technologies' Interest Expenses history runs 7 years deep, the most recent figure standing at $13.2 million for Q4 2025.
- Quarterly Interest Expenses rose 29.07% year-over-year to $13.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.2 million (up 29.07% YoY) and the FY2025 annual result came in at $13.2 million, up 29.07% from the prior year.
- Interest Expenses was $13.2 million for Q4 2025 at PRF Technologies, up from $10.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $13.2 million in Q4 2025 and bottomed at $21000.0 in Q4 2021.
- A 5-year average of $7.2 million and a median of $6.9 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses plunged 99.4% — and 2022, when it jumped 25500.0%.
- PRF Technologies' Interest Expenses stood at $21000.0 in 2021, then soared by 25500.0% to $5.4 million in 2022, then climbed by 28.81% to $6.9 million in 2023, then jumped by 47.96% to $10.2 million in 2024, then rose by 29.07% to $13.2 million in 2025.
- Business Quant data shows PRFX's Interest Expenses at $13.2 million in Q4 2025, $10.2 million in Q4 2024, and $6.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | PRF Technologies | 714,066.24 | -326,933.76 | - | 13.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.22 Mn |
| Dec 31, 2025 | 13.22 Mn |
| Dec 31, 2024 | 10.25 Mn |
| Dec 31, 2024 | 10.25 Mn |
| Dec 31, 2023 | 6.93 Mn |
| Dec 31, 2023 | 6.93 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | 21,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 3.48 Mn |
| Dec 31, 2020 | 3.48 Mn |
| Dec 31, 2019 | 275,000.00 |
| Dec 31, 2019 | 275,000.00 |